Conference Coverage
News
GABA falls short for type 1 diabetes prevention in children
BARCELONA – There was no difference in pancreatic beta-cell function as measured by meal-stimulated C-peptide levels.
Conference Coverage
SUSTAIN 10: Weight loss, glycemic control better with semaglutide than liraglutide
BARCELONA – Once-weekly treatment with subcutaneous semaglutide yielded greater reductions in HbA1c and body weight than once-daily...
Conference Coverage
Certain diabetes drugs may thwart dementia
COPENHAGEN – Intriguing findings from a Danish national registry study.
Conference Coverage
Obesity ups type 2 diabetes risk far more than lifestyle, genetics
BARCELONA –
Conference Coverage
Liraglutide ‘option’ for treating pediatric type 2 diabetes
BARCELONA – ELLIPSE trial shows clinicians aren’t limited to metformin and insulin for children with diabetes.
Conference Coverage
Smoking, inactivity most powerful post-MI lifestyle risk factors
PARIS –
Conference Coverage
COMISAIR: CGM ‘makes the difference’ in type 1 diabetes
BARCELONA –
Conference Coverage
RISE analyses highlight further youth vs. adult T2D differences
BARCELONA – New data delve further into the differences in insulin sensitivity and glucose response in youth and adults with type 2 diabetes.
Conference Coverage
CONCLUDE data inconclusive on hypoglycemia risk for degludec vs. glargine
BARCELONA – The primary endpoint of the study was not met, thus differences between the long-acting insulins could not be confirmed.
Conference Coverage
Machine learning–derived risk score predicts heart failure risk in diabetes patients
Highest WATCH-DM scores linked to 5-year heart failure risk approaching 20%.